永鴻生技 News Releases

[Eternal Biotech] Announcement on the Board's Election of the Chairman

Eternal International Biotech Co., Ltd. announced on May 22 that following a board resolution, Chung… · 2026-05-22

[Younghong Biotech] Announcement regarding the re-election of Audit Committee members due to expiration of term

Younghong Biotech held a re-election of Audit Committee members following term expiration. The four … · 2026-05-22

[YongHoon Biotech] Shareholders' meeting approves waiver of non-compete restrictions for new directors

On May 22, 2026, YongHoon Biotech passed a resolution at its annual shareholders' meeting to waive n… · 2026-05-22

[YongHong Biotech] Announcement Regarding the Determination of Record Date for Cash Dividend

YongHong Biotech decided on May 22, 2026, to distribute a cash dividend of 1.51 TWD per common share… · 2026-05-22

[Everlight Biotech] Announcement on the Re-election of Directors (Including Independent Directors) at the 2026 Annual General Meeting

On May 22, 2026, Everlight Biotech conducted a full re-election of its board of directors following … · 2026-05-22

[Everest Medicines] Announcement regarding the expiration of terms for the first Compensation Committee

Everest Medicines announced that the terms of the members of its first Compensation Committee have e… · 2026-05-22

[Eternal Materials] Announcement of Important Resolutions of the 2026 Annual Shareholders' Meeting

Eternal Materials held its annual shareholders' meeting on May 22, 2026, and approved important item… · 2026-05-22

[Yung Hung Bio-tech] Announcement of the Company's Lease of Right-of-Use Assets for Real Estate from a Related Party (Supplementary Announcement of Change in Transaction Counterparty)

Yung Hung Bio-tech announced the acquisition of right-of-use assets for leasing office space in Taip… · 2026-05-06

[Yung Hung Bio-tech] Announcement of the Company's Lease of Right-of-Use Assets for Real Estate from a Related Party (Supplementary Announcement of Change in Transaction Counterparty)

Yung Hung Bio-tech announced the acquisition of right-of-use assets for leasing office space in Taip… · 2026-05-06

[Wing Biotech] May 2026 Revenue Reaches NT$126 Million (YoY +19.3%)

Wing Biotech (6936) announced its May 2026 revenue of NT$126.13 million, representing a 19.3% increa… · 2026-05-01

【Everlight Bio-Tech】Announcement of the company's board of directors' approval of the Q1 2026 individual financial report

Everlight Bio-Tech announced that its individual financial report for the first quarter of 2026 (Jan… · 2026-04-29

【Everlight Bio-Tech】Announcement of the company's board of directors' approval of the Q1 2026 individual financial report

Everlight Bio-Tech announced that its individual financial report for the first quarter of 2026 (Jan… · 2026-04-29

[Vetnostrum] Announcement of the date of the Board of Directors meeting for the Q1 2026 financial report

Vetnostrum Animal Health announced that its Board of Directors will meet on April 29, 2026, to discu… · 2026-04-17

[Vetnostrum] Announcement of the date of the Board of Directors meeting for the Q1 2026 financial report

Vetnostrum Animal Health announced that its Board of Directors will meet on April 29, 2026, to discu… · 2026-04-17

【Yonghong Biotech】April 2026 Monthly Revenue 1.32 Billion (YoY +27.2%)

Yonghong Biotech's monthly revenue for April 2026 reached 1.32 billion NTD, marking a +27.2% year-on… · 2026-04-01

【Yonghong Biotech】April 2026 Monthly Revenue 1.32 Billion (YoY +27.2%)

Yonghong Biotech's monthly revenue for April 2026 reached 1.32 billion NTD, marking a +27.2% year-on… · 2026-04-01

[Yung Hung Biotech] March 2026 Monthly Revenue NT$132M (YoY +15.7%)

Yung Hung Biotech announced its monthly revenue for March 2026, which reached NT$132 million, a 15.7… · 2026-03-01

[Yung Hung Biotech] March 2026 Monthly Revenue NT$132M (YoY +15.7%)

Yung Hung Biotech announced its monthly revenue for March 2026, which reached NT$132 million, a 15.7… · 2026-03-01

Yung Hung Biotech: February 2026 Revenue Reaches NT$92 Million (YoY -11.7%)

Yung Hung Biotech (6936) has announced its financial results for February 2026. The company's revenu… · 2026-02-01

Yung Hung Biotech: February 2026 Revenue Reaches NT$92 Million (YoY -11.7%)

Yung Hung Biotech (6936) has announced its financial results for February 2026. The company's revenu… · 2026-02-01